Stem Cell Stocks 5/24/09: The Week That Was

It was flat week for the most part for the stem cell stocks. Overall, the stocks that have fallen the hardest in the sector have finally begun to level out. As a result, now may finally be the time to consider buying select names in the sector. The only stem cell stock that has shown consistent upward movement over the last 3 months has been Geron Corp. (GERN).







Top Stem Cell Stock Performer(s) for Last Week:

- Bioheart Inc. (BHRT.OB) = Up 38%; The low volume continues to yield wild swings. If you recall, Bioheart was the worst performer of the group the previous week.



Worst Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Down -22% for the week; With ISCO.OB being the best performer the previous week, we mentioned that it would be a good stock to short due to profit taking. It looks like we were right.

Stem Cell Stocks Current Price and % Up or Down 5/18/09 - 5/22/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.39; Unchanged
Aastrom Biosciences (ASTM) = Cur Price: $0.36; Down -3%
BioTime, Inc. (BTIM) = Cur Price: $2.64; Up 2%
Celgene Corp (CELG) = Cur Price: $39.43; Down -1%
Cytori Therapeutics (CYTX) = Cur Price: $2.88; Up 3%
Geron Corp (GERN) = Cur Price: $6.79; Up 8%
ThermoGenesis (KOOL) = Cur Price: $0.553; Down -3%
Osiris Therapeutics (OSIR) = Cur Price: $12.02; Down -3%
StemCell Inc. (STEM) = Cur Price: $1.68; Down -4%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.13; Down -7%
Athersys Inc. (ATHX) = Cur Price: $0.89; Up 9%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.076; Down -5%
Bioheart Inc. (BHRT) = Cur Price: $0.90; Up 38%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0048; Down -13%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.15; Down -4%
Neuralstem (CUR) = Cur Price: $1.10; Down -7%
International Stem Cell (ISCO.OB) = Cur Price: $0.68; Down -22%
MultiCell Technologies (MCET.OB) = Cur Price: $0.012; Up 14%
Pluristem Therapeutics (PSTI) = Cur Price: $1.16; Down -19%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.065; Unchanged
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.05; Up 2%

Catalyst(s) for the Week:

Nothing has changed from the last few months.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.